Results: 26

Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer

Einstein (Säo Paulo); 15 (3), 2017
ABSTRACT Objective To assess the cost-effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer. Methods An analytical decision model was developed to determine the cost-effectiveness of chemohormonal therapy versus androgen depr...

Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review

Summary Aromatase inhibitors have emerged as an alternative endocrine therapy for the treatment of hormone sensitive breast cancer in postmenopausal women. The use of third-generation inhibitors represented by exemestane, letrozol and anastrozole is currently indicated. Anastrozole is a nonsteroidal comp...

Elección del mejor antidepresivo en pacientes con cáncer de mama en tratamiento con tamoxifeno: revisión de la evidencia básica y clínica

Rev. méd. Chile; 144 (10), 2016
Tamoxifen (Tmf), is a standard of care for women with estrogen receptor positive (ER+) breast cancer. Endoxifen is a Tmf metabolite generated by cytochrome P450 2D6 (CYP2D6). Antidepressive agents (AD) are often prescribed to women with breast cancer not only for depression, but also for anxiety and hot ...

Prostate cancer

Salud pública Méx; 58 (2), 2016
Abstract Prostate cancer is the most frequent tumor found in men worldwide and in Mexico in particular. Age and family history are the main risk factors. The diagnosis is made by prostate biopsy in patients with abnormalities detected in their prostate-specific antigen (PSA) levels or digital rectal exam...

Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice

Acta cir. bras; 31 (4), 2016
PURPOSE: To evaluate the effects of letrozole (Ltz) in carcinogen+estrogen-induced endometrial hyperplasia. METHODS: BALB/c female mice were divided into four groups of 12 animals each receiving an intrauterine dose of N-ethyl-N-nitrosourea (ENU) and weekly subcutaneous injections of estradiol hexaid...

Informe de evaluación rápida de tecnología sobre seguridad y efectividad de degarelix para cáncer de próstata
Rapid evaluation report of technology on safety and effectiveness of degarelix for prostate cancer

Hoy en día, el cáncer de próstata se considera uno de los problemas médicos más importantes a los que se enfrenta la población masculina. En Europa, el cáncer de próstata es la neoplasia sólida más frecuente, con una incidencia de 214 casos por 1000 varones, superando en número a los cánceres...